Autosomal dominant spondyloepiphyseal dysplasia tarda

From WikiMD's WELLNESSPEDIA

Definition[edit]

Autosomal domiant spondyloepiphyseal dysplasia tarda (autosomal dominant SEDT) is an inherited condition that affects bone growth.

Cause[edit]

Some cases of autosomal dominant SEDT may be caused by changes (mutations) in the COL2A1 gene.

Inheritance[edit]

Autosomal dominant pattern, a 50/50 chance.

As the name suggests, the condition is inherited in an autosomal dominant manner.

Signs and symptoms[edit]

Signs and symptoms are generally physically apparent by puberty; however, abnormalities may be seen on X-ray at an earlier age. Affected people may have skeletal abnormalities, short stature (with a short neck and trunk, specifically), scoliosis, kyphosis, lumbar hyperlordosis (exaggerated curvature of the lower back), and early-onset progressive osteoarthritis of the hips and knees.

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 80%-99% of people have these symptoms

  • Abnormality of epiphysis morphology(Abnormal shape of end part of bone)
  • Arthralgia(Joint pain)
  • Barrel-shaped chest(Barrel chest)
  • Disproportionate short stature
  • Platyspondyly(Flattened vertebrae)
  • Short thorax(Shorter than typical length between neck and abdomen)
  • Spondyloepiphyseal dysplasia
  • Thoracic kyphosis
  • Upper limb undergrowth(Short arms)

30%-79% of people have these symptoms

Diagnosis[edit]

Treatment[edit]

Treatment is based on the signs and symptoms present in each person and may include surgery and pain management strategies.

NIH genetic and rare disease info[edit]

Autosomal dominant spondyloepiphyseal dysplasia tarda is a rare disease.


WikiMD logo

This article is a stub

You can help WikiMD by registering and expanding it with useful details, internal links, formatting, and categories.

Editing is available only to registered and verified users. WikiMD is a comprehensive, free health and wellness encyclopedia.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.